Search Results - "Felipe, Cláudia Rosso"
-
1
Prolonged Delayed Graft Function Is Associated with Inferior Patient and Kidney Allograft Survivals
Published in PloS one (17-12-2015)“…It is unclear if there is an association between the duration of delayed graft function (DGF) and kidney transplant (KT) outcomes. This study investigated the…”
Get full text
Journal Article -
2
Transition from antigenemia to quantitative nucleic acid amplification testing in cytomegalovirus-seropositive kidney transplant recipients receiving preemptive therapy for cytomegalovirus infection
Published in Scientific reports (27-07-2022)“…Due to the high costs, the strategy to reduce the impact of cytomegalovirus (CMV) after kidney transplant (KT) involves preemptive treatment in low and…”
Get full text
Journal Article -
3
Clinical and pathological features of thrombotic microangiopathy influencing long-term kidney transplant outcomes
Published in PloS one (2020)“…Thrombotic microangiopathy (TMA) in post-transplant setting has heterogeneous clinical manifestations. We retrospectively studied data of 89 patients with…”
Get full text
Journal Article -
4
Ureterocalicostomy with lower pole nephrectomy in a renal transplant: A case report
Published in American journal of transplantation (01-09-2018)“…As the number of kidney transplants continues to rise, so does the number and complexities of surgical‐related complications, which may be associated with…”
Get full text
Journal Article -
5
Long-Term Follow-Up of De Novo Use of mTOR and Calcineurin Inhibitors After Kidney Transplantation
Published in Therapeutic drug monitoring (01-02-2016)“…Long-term efficacy and safety of de novo use of the mammalian target of rapamycin inhibitors (mTORi) have been evaluated primarily using registry data. This…”
Get full text
Journal Article -
6
Targeted preemptive therapy according to perceived risk of CMV infection after kidney transplantation
Published in The Brazilian journal of infectious diseases (01-11-2016)“…The identification of the best strategy to manage cytomegalovirus infection is hampered by uncertainties regarding the risk/benefit ratios of universal…”
Get full text
Journal Article -
7
Influence of epidemiology, immunosuppressive regimens, clinical presentation, and treatment on kidney transplant outcomes of patients diagnosed with tuberculosis: A retrospective cohort analysis
Published in American journal of transplantation (01-05-2019)“…Tuberculosis (TB) mortality is high among kidney transplant (KT) recipients. Although local epidemiology is an important factor, diagnostic/therapeutic…”
Get full text
Journal Article -
8
Long-term Efficacy and Safety of Everolimus Versus Mycophenolate in Kidney Transplant Recipients Receiving Tacrolimus
Published in Transplantation (01-02-2022)“…The short-term efficacy and safety of everolimus in combination with tacrolimus have been described in several clinical trials. Yet, detailed long-term data…”
Get full text
Journal Article -
9
Is There Sufficient Evidence Justifying Limited Access of Jehovah’s Witness Patients to Kidney Transplantation?
Published in Transplantation (01-01-2021)“…Jehovah's Witnesses (JWs) refuse blood transfusions due to religious issues. This situation may impact kidney transplantation (KT) outcomes in case of…”
Get full text
Journal Article -
10
Decreased incidence of acute rejection without increased incidence of cytomegalovirus (CMV) infection in kidney transplant recipients receiving rabbit anti-thymocyte globulin without CMV prophylaxis - a cohort single-center study
Published in Transplant international (01-02-2021)“…Induction therapy with rabbit anti-thymocyte globulin (rATG) in low-risk kidney transplant recipients (KTR) remains controversial, given the associated…”
Get more information
Journal Article -
11
Simultaneous Determination of Everolimus, Sirolimus, Tacrolimus, and Cyclosporine-A by Mass Spectrometry
Published in Transplantation proceedings (01-06-2020)“…Measurement of immunosuppressive drug concentrations cyclosporine A (CyA), tacrolimus (TAC), sirolimus (SIR), and everolimus (EVE) in blood is an important…”
Get full text
Journal Article -
12
Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus
Published in Transplantation (01-11-2015)“…BACKGROUNDThere is no evidence on the incidence of subclinical inflammation and scaring lesions in patients receiving tacrolimus (TAC) minimization and…”
Get full text
Journal Article -
13
Prospective randomized study comparing everolimus and mycophenolate sodium in de novo kidney transplant recipients from expanded criteria deceased donor
Published in Transplant international (01-11-2019)“…The optimal immunosuppressive regimen for recipients of expanded criteria donor (ECD) kidneys has not been identified. In this single-center study, 171…”
Get more information
Journal Article -
14
CYP3A53 and CYP2C83 variants influence exposure and clinical outcomes of tacrolimus-based therapy
Published in Pharmacogenomics (01-01-2020)“…The influence of variants in pharmacokinetics-related genes on long-term exposure to tacrolimus (TAC)-based therapy and clinical outcomes was investigated…”
Get full text
Journal Article -
15
Is low birth weight an additional risk factor for hypertension in paediatric patients after kidney transplantation?
Published in Journal of developmental origins of health and disease (01-02-2020)“…Hypertension (HTN) remains a common complication after kidney transplantation among paediatric patients. Although low birth weight (LBW) has been implicated as…”
Get more information
Journal Article -
16
Renal function at 12 months of kidney transplantation comparing tacrolimus and mycophenolate with tacrolimus and mTORi in donors with different KDPI ranges. A multicenter cohort study using propensity scoring
Published in Frontiers in transplantation (16-10-2023)“…The combination of tacrolimus/mTORi compared to tacrolimus/mycophenolate (MMF) was shown to be safe in the TRANSFORM trial. For donors with a high KDPI (Kidney…”
Get full text
Journal Article -
17
The Association Between Kidney Donor Profile Index and 1-y Graft Function
Published in Transplantation direct (01-05-2023)“…The association between Kidney Donor Profile Index (KDPI) and 1-y estimated glomerular filtration rate (eGFR) with long-term kidney graft survival is well…”
Get full text
Journal Article -
18
Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens
Published in Pharmacotherapy (01-02-2016)“…Study Objective To evaluate the safety and tolerability of immunosuppressive drugs used in a planned randomized conversion from a calcineurin inhibitor,…”
Get full text
Journal Article -
19
The effect of anti‐thymocyte globulin and everolimus on the kinetics of cytomegalovirus viral load in seropositive kidney transplant recipients without prophylaxis
Published in Transplant infectious disease (01-08-2018)“…Background The use of mTOR inhibitors is associated with lower incidence of CMV infections but its effect on viral load has not been investigated. Aims,…”
Get full text
Journal Article -
20
Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant Recipients
Published in Frontiers in pharmacology (14-11-2018)“…Monitoring of immunosuppressive drugs, such as calcineurin and mTOR inhibitors, is essential to avoid undesirable kidney transplant outcomes. Polymorphisms in…”
Get full text
Journal Article